CRC development involves multiple genetic and epigenetic alterations, which results in the dysregulation of oncogenes and tumor suppressor genes.30 Functional loss of PTEN, activating mutation in Ras or PIK3CA, and stimulation by various growth factors in CRC represent mechanisms for activating the PI3K/AKT pathway. The gene discussed is AKT1; the disease is colorectal carcinoma.